ACN
54
2
ZTS
38
-5
AXP
67
-3
AON
43
-4
DE
46
-7
SWK
58
-6
DTE
65
-3
LEG
22
-6
XYL
49
-5
PNW
70
-3
PVH
45
-2
ESS
48
-3
NFLX
62
-2
PPL
59
-3
MOS
38
-2
MDLZ
28
-6
PM
47
-3
ETR
63
-2
ABT
44
-4
FLS
65
-3
ACN
54
2
ZTS
38
-5
AXP
67
-3
AON
43
-4
DE
46
-7
SWK
58
-6
DTE
65
-3
LEG
22
-6
XYL
49
-5
PNW
70
-3
PVH
45
-2
ESS
48
-3
NFLX
62
-2
PPL
59
-3
MOS
38
-2
MDLZ
28
-6
PM
47
-3
ETR
63
-2
ABT
44
-4
FLS
65
-3
Financhill
Back

Sunshine Biopharma Quote, Financials, Valuation and Earnings

Invest in the Next Big AI Disruptor Today

Learn More
Sell
22

SBFM
Sunshine Biopharma

Last Price:
3.15
Seasonality Move:
-20.95%

7 Day Trial

ALL ACCESS PASS

$ 7

AI Tech Innovator Poised for Strategic Buyouts Invest Now

Learn More

Sunshine Biopharma Price Quote

$3.15
+0.17 (+5.87%)
(Updated: October 4, 2024 at 6:55 PM ET)

Sunshine Biopharma Key Stats

Sell
22
Sunshine Biopharma (SBFM) is a Sell
Day range:
$2.91 - $3.05
52-week range:
$2.42 - $740.00
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.13
P/B ratio:
0.16%
Volume:
46.1K
Avg. volume:
232.5K
1-year change:
-99.51%
Market cap:
$3.8M
Revenue:
$24.1M
EPS:
$-234.1

How Much Does Sunshine Biopharma Make?

Is Sunshine Biopharma Growing As A Company?

  • What Is Sunshine Biopharma's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.67%
  • What Is Sunshine Biopharma's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Sunshine Biopharma Stock Price Performance

What Is Sunshine Biopharma 52-Week High & Low?

Sunshine Biopharma Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Sunshine Biopharma?

Is Sunshine Biopharma Cash Flow Positive?

  • What Is SBFM Cash Flow From Operations?
    Cash flow from operations (TTM) is -$10.9M
  • What Is Sunshine Biopharma’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $5.3M
  • What Is Sunshine Biopharma’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$1.5M

Sunshine Biopharma Return On Invested Capital

  • Is Management Doing A Good Job?
    SBFM return on invested capital is -16.06%
  • What Is Sunshine Biopharma Return On Assets?
    ROA measures how assets are converting to revenues and is -12.72%
  • What Is SBFM Return On Equity?
    ROE is a measure of profitability and is -16.06%

Sunshine Biopharma Earnings Date & Stock Price

Sunshine Biopharma Competitors

  • Who Are Sunshine Biopharma's Competitors?
    Below is a list of companies who compete with Sunshine Biopharma or are related in some way:
    • Acasti Pharma Inc (ACST)
    • Aurinia Pharmaceuticals Inc (AUPH)
    • Edesa Biotech Inc (EDSA)
    • Lexaria Bioscience Corp (LEXX)
    • Xenon Pharmaceuticals Inc (XENE)

Sunshine Biopharma Dividend Yield

Sunshine Biopharma Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 67.3% 3.37%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 300.00
Upside from Last Price: 9983.02%

Major Shareholders

  • How many SBFM shares are owned by institutional investors?
    9M SBFM shares are owned by institutional investors
  • How many SBFM shares are owned by insiders?
    23.9M SBFM shares are owned by insiders